Ardeparin and danaparoid.
出版信息
Dimens Crit Care Nurs. 2000 Jul-Aug;19(4):13-4. doi: 10.1097/00003465-200019040-00004.
Abstract
摘要
相似文献
1
Ardeparin and danaparoid.
Dimens Crit Care Nurs. 2000 Jul-Aug;19(4):13-4. doi: 10.1097/00003465-200019040-00004.
2
Ardeparin and danaparoid for prevention of deep vein thrombosis.阿地肝素和达那肝素预防深静脉血栓形成。
Med Lett Drugs Ther. 1997 Oct 10;39(1011):94-5.
3
Safe anticoagulation with danaparoid in pregnancy and lactation.
Thromb Haemost. 2004 Jul;92(1):211.
4
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).低分子量肝素或类肝素与标准普通肝素治疗急性缺血性卒中（Cochrane系统评价）
Stroke. 2002 Jul;33(7):1925-6. doi: 10.1161/01.str.0000018820.99077.46.
5
Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgery.达那肝素与依诺肝素预防髋关节置换术后深静脉血栓形成的成本效益比较。
Am J Orthop (Belle Mead NJ). 1999 Apr;28(4):229-31.
6
Danaparoid: a review of its use in thromboembolic and coagulation disorders.达那肝素：关于其在血栓栓塞和凝血障碍中应用的综述
Drugs. 2002;62(15):2283-314. doi: 10.2165/00003495-200262150-00016.
7
[Danaparoid (orgaran) for continuous venovenous hemodiafiltration in a patient with heparin-induced thrombocytopenia].[达那肝素（奥加兰）用于肝素诱导的血小板减少症患者的持续静脉-静脉血液透析滤过治疗]
Ann Fr Anesth Reanim. 1998;17(1):82-3. doi: 10.1016/s0750-7658(97)80191-8.
8
Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia.达那肝素用于既往有肝素诱导的血小板减少症患者的体外循环。
Br J Haematol. 1997 Sep;98(3):657-9. doi: 10.1046/j.1365-2141.1997.2633080.x.
9
Failure of danaparoid anticoagulation for cardiopulmonary bypass.达那肝素用于体外循环抗凝失败。
J Thorac Cardiovasc Surg. 2000 Jan;119(1):167-8. doi: 10.1016/s0022-5223(00)70233-9.
10
Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.体外循环与肝素诱导的血小板减少症：达那肝素抗凝的陷阱
J Thorac Cardiovasc Surg. 2000 Aug;120(2):428-9. doi: 10.1067/mtc.2000.108285.
Zotero 插件